Literature DB >> 26698019

Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network.

Markus Kipp1, Tanja Hochstrasser2, Christoph Schmitz2, Cordian Beyer3.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease that shows a female-to-male gender prevalence and alleviation of disease activity during late stage pregnancy. In MS-related animal models, sex steroids ameliorate symptoms and protect from demyelination and neuronal damage. Underlying mechanisms of these protective avenues are continuously discovered, in part by using novel transgenic animal models. In this review article, we highlight the regulation of glia cell function by female sex steroids. We specifically focus on the relevance of glia cells for immune cell recruitment into the central nervous system and show how estrogen and progesterone can modulate these cell-cell communication pathways. Since MS is considered to have a strong neurodegenerative component, principal neuroprotective mechanisms, exerted by sex-steroids will be discussed as well. Activation of steroid receptors might not just act as immunosuppressant but at the same time harmonize brain-intrinsic networks to dampen neurodegeneration and, thus, disease progression in MS.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Astroglia; Estrogen; Immune cells; Inflammation; Invasion; Microglia; Multiple sclerosis; Neuroinflammation; Neuroprotection; Progesterone

Mesh:

Substances:

Year:  2015        PMID: 26698019     DOI: 10.1016/j.neubiorev.2015.11.016

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  9 in total

1.  PLXNA3 Variant rs5945430 is Associated with Severe Clinical Course in Male Multiple Sclerosis Patients.

Authors:  Moaz Qureshi; Mohamed Hatem; Raed Alroughani; Sindhu P Jacob; Rabeah Abbas Al-Temaimi
Journal:  Neuromolecular Med       Date:  2017-05-23       Impact factor: 3.843

2.  Estrogen Attenuates Local Inflammasome Expression and Activation after Spinal Cord Injury.

Authors:  Adib Zendedel; Fabian Mönnink; Gholamreza Hassanzadeh; Arash Zaminy; Malek Masoud Ansar; Pardes Habib; Alexander Slowik; Markus Kipp; Cordian Beyer
Journal:  Mol Neurobiol       Date:  2017-01-27       Impact factor: 5.590

3.  Administration of 17β-Estradiol Improves Motoneuron Survival and Down-regulates Inflammasome Activation in Male SOD1(G93A) ALS Mice.

Authors:  Marius Heitzer; Sarah Kaiser; Mithila Kanagaratnam; Adib Zendedel; Philipp Hartmann; Cordian Beyer; Sonja Johann
Journal:  Mol Neurobiol       Date:  2016-12-12       Impact factor: 5.590

4.  Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice.

Authors:  Riya Thomas; Paulina Zuchowska; Alan W J Morris; Felecia M Marottoli; Sangeeta Sunny; Ryan Deaton; Peter H Gann; Leon M Tai
Journal:  Acta Neuropathol Commun       Date:  2016-10-27       Impact factor: 7.801

Review 5.  Sex Steroids, Adult Neurogenesis, and Inflammation in CNS Homeostasis, Degeneration, and Repair.

Authors:  Tracy A Larson
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-30       Impact factor: 5.555

Review 6.  Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine.

Authors:  Lucie Kolatorova; Jana Vitku; Josef Suchopar; Martin Hill; Antonin Parizek
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

7.  The Genomic Architecture of Pregnancy-Associated Plasticity in the Maternal Mouse Hippocampus.

Authors:  Alper Celik; Max Somer; Bharti Kukreja; Taiyi Wu; Brian T Kalish
Journal:  eNeuro       Date:  2022-09-28

Review 8.  A Fatal Alliance between Microglia, Inflammasomes, and Central Pain.

Authors:  Stefanie Hoffmann; Cordian Beyer
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

9.  High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients.

Authors:  Lisa Stefanie Hönikl; Friederike Lämmer; Jens Gempt; Bernhard Meyer; Jürgen Schlegel; Claire Delbridge
Journal:  J Neurooncol       Date:  2020-04-02       Impact factor: 4.130

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.